Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on June 9, 2016. The report details the final results of a rights offering of common stock to shareholders of record as of May 13, 2016, which expired on May 31, 2016.
Key Financial Metrics
- Gross Proceeds: Approximately $19,818,611.
- Shares Issued: 5,978,465 shares of common stock.
- Subscription Price: $3.315 per share (calculated as 85% of the $3.90 closing price on May 31, 2016, which was lower than the $4.25 cap).
- Other Metrics: The filing does not provide data on revenue, profit, operating cash flow, margins, debt, or liquidity ratios.
Material Changes
The primary material change is the increase in equity capital resulting from the successful completion of the rights offering. The company issued nearly 6 million shares, raising approximately $19.8 million in gross proceeds. No reduction in subscriptions was made to preserve tax attributes, such as net operating loss carryforwards.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the rights offering mechanics. The company confirmed that oversubscribed amounts were returned to shareholders and that shares were issued and delivered according to shareholder interests.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting or administrative fees, as only gross proceeds are stated.
- Confirm the impact of the 5,978,465 new shares on existing shareholder dilution.
- Review the company's most recent 10-Q or 10-K for current cash balances and debt levels, as this 8-K does not report liquidity status.
- Check subsequent filings for the utilization of the raised capital.